Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Nov 4, 2024, 4:00 PM
1.970
-0.030 (-1.50%)
Pre-market: Nov 5, 2024, 4:01 AM EST

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $392.45 million. The enterprise value is $472.28 million.

Market Cap 392.45M
Enterprise Value 472.28M

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, before market open.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

ESPR has 196.22 million shares outstanding. The number of shares has increased by 76.93% in one year.

Shares Outstanding 196.22M
Shares Change (YoY) +76.93%
Shares Change (QoQ) -0.45%
Owned by Insiders (%) 0.72%
Owned by Institutions (%) 68.87%
Float 194.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.05
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.70
EV / EBITDA 94.65
EV / EBIT 95.45
EV / FCF n/a

Financial Position

The company has a current ratio of 1.97

Current Ratio 1.97
Quick Ratio 1.42
Debt / Equity n/a
Debt / EBITDA 46.08
Debt / FCF n/a
Interest Coverage 0.09

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 1.05%
Return on Capital (ROIC) 8.16%
Revenue Per Employee $1.16M
Profits Per Employee -$410,404
Employee Count 240
Asset Turnover 0.95
Inventory Turnover 1.66

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +94.18% in the last 52 weeks. The beta is 0.95, so ESPR's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change +94.18%
50-Day Moving Average 1.88
200-Day Moving Average 2.21
Relative Strength Index (RSI) 49.56
Average Volume (20 Days) 2,752,555

Short Selling Information

The latest short interest is 35.39 million, so 18.03% of the outstanding shares have been sold short.

Short Interest 35.39M
Short Previous Month 37.47M
Short % of Shares Out 18.03%
Short % of Float 18.16%
Short Ratio (days to cover) 10.64

Income Statement

In the last 12 months, ESPR had revenue of $277.79 million and -$98.50 million in losses. Loss per share was -$0.68.

Revenue 277.79M
Gross Profit 169.78M
Operating Income 4.95M
Pretax Income -98.50M
Net Income -98.50M
EBITDA 4.99M
EBIT 4.95M
Loss Per Share -$0.68
Full Income Statement

Balance Sheet

The company has $189.30 million in cash and $269.14 million in debt, giving a net cash position of -$79.83 million or -$0.41 per share.

Cash & Cash Equivalents 189.30M
Total Debt 269.14M
Net Cash -79.83M
Net Cash Per Share -$0.41
Equity (Book Value) -344.22M
Book Value Per Share -1.77
Working Capital 169.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.76 million and capital expenditures -$150,000, giving a free cash flow of -$9.91 million.

Operating Cash Flow -9.76M
Capital Expenditures -150,000
Free Cash Flow -9.91M
FCF Per Share -$0.05
Full Cash Flow Statement

Margins

Gross margin is 61.12%, with operating and profit margins of 1.78% and -35.46%.

Gross Margin 61.12%
Operating Margin 1.78%
Pretax Margin -35.46%
Profit Margin -35.46%
EBITDA Margin 1.80%
EBIT Margin 1.78%
FCF Margin -3.57%

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -76.93%
Shareholder Yield -76.93%
Earnings Yield -25.10%
FCF Yield -2.52%

Analyst Forecast

The average price target for ESPR is $8.17, which is 308.50% higher than the current price. The consensus rating is "Buy".

Price Target $8.17
Price Target Difference 308.50%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 63.73%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ESPR has an Altman Z-Score of -4.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.5
Piotroski F-Score 5